Aniline mustard

CAS No. 553-27-5

Aniline mustard( Lymphocin | Mesylerythrol | NSC-18429 )

Catalog No. M27143 CAS No. 553-27-5

Aniline mustard is alkylating mustard with anti-neoplastic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Aniline mustard
  • Note
    Research use only, not for human use.
  • Brief Description
    Aniline mustard is alkylating mustard with anti-neoplastic activity.
  • Description
    Aniline mustard is alkylating mustard with anti-neoplastic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lymphocin | Mesylerythrol | NSC-18429
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    553-27-5
  • Formula Weight
    218.12
  • Molecular Formula
    C10H13Cl2N
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ClCCN(CCCl)c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Waxman K, et al. Lisofylline decreases white cell adhesiveness and improves survival after experimental hemorrhagic shock. Crit Care Med. 1996 Oct;24(10):1724-8.
molnova catalog
related products
  • Ensartinib hydrochlo...

    Ensartinib dihydrochloride is a potent new-generation ALK inhibitor with high activity against CNS metastases and a broad range of known crizotinib-resistant ALK mutations.

  • Soretolide

    Soretolide (D2916) is a small molecule compound that is used to treat epilepsy.

  • BMf-BH3

    BMf-BH3 belongs to the Bcl-2 apoptosis mediator family. This peptide belongs to the Bcl-2 apoptosis mediator family. Bmf is a key player in histone deacetylase (HDAC) inhibition, which alters the balance between deacetylation and acetylation.